Melatonin Dose Study, Steroid Warning Show Both Sides Of Coin For US Supplement Industry Image
Latest Public Perception Peril Prompted By JAMA Research Letter, FDA SARMs Consumer Alert
Executive Summary
Separate criticisms show opposite sides of the coin of public perception constantly flipping for businesses large and small making and marketing supplements available in US.
You may also be interested in...
‘Lack Of Understanding’ Here, Spiked Product There Add Up To US Supplement Industry Image Problem
Research suggesting FDA more stringently regulate claims for fish oil supplements impresses industry as another sign the agency’s regulation and the requirements fulfilled by compliant businesses aren’t appreciated or understood. FDA announcement of ED drugs in products labeled as supplements shows agency must be aware students are starting or returning to classes.
COVID-19 Stress Drives Anxiety-Reducing Supplement Sales Up 79% In US Since 2018
Sales for anxiety/stress relief dietary supplements in 2020 grew 79% from 2018, eclipsing growth of 22% for general herbal supplements during the same comparison period. Stress-relief supplements including St. John’s wart, ashwagandha and cannabinoids continue to grow in popularity.
Mandatory Recall Guidance Positions FDA For ‘Robust’ Use Of Authority
Final guidance on mandatory recall authority under FSMA specifies how FDA allows firms opportunities for voluntary recalls and evidence it may consider when deciding whether to mandate a recall. But a consumer advocacy group critical of FDA says the guidance adds nothing for protecting public health.